Current Status of the Use of Salvaged Blood in Metastatic Spine Tumour Surgery

다국어 초록 (Multilingual Abstract)

To review the current status of salvaged blood transfusion (SBT) in metastatic spine tumour surgery (MSTS), with regard to its safety and efficacy, contraindications, and adverse effects. We also aimed to establish that the safety and adverse event profile of SBT is comparable and at least equal to that of allogeneic blood transfusion. MEDLINE and Scopus were used to search for relevant articles, based on keywords such as “cancer surgery,” “salvaged blood,” and “circulating tumor cells.” We found 159 articles, of which 55 were relevant; 20 of those were excluded because they used other blood conservation techniques in addition to cell salvage. Five articles were manually selected from reference lists. In total, 40 articles were reviewed. There is sufficient evidence of the clinical safety of using salvaged blood in oncological surgery. SBT decreases the risk of postoperative infections and tumour recurrence. However, there are some limitations regarding its clinical applications, as it cannot be employed in cases of sepsis. In this review, we established that earlier studies supported the use of salvaged blood from a cell saver in conjunction with a leukocyte depletion filter (LDF). Furthermore, we highlight the recent emergence of sufficient evidence supporting the use of intraoperative cell salvage without an LDF in MSTS.

참고문헌 (Reference)

1 International Agency for Research on Cancer, "World cancer factsheet" 2012

2 Kumar N, "What is the role of autologous blood transfusion in major spine surgery?" 41 : 89-95, 2012

3 Kumar N, "Use of intraoperative cellsalvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review" 15 : e33-e41, 2014

4 Catling S, "Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood" 63 : 1332-1338, 2008

5 Hansen E, "Tumor cells in blood shed from the surgical field" 130 : 387-393, 1995

6 Allard WJ, "Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases" 10 : 6897-6904, 2004

7 Yaw PB, "Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery?" 231 : 490-491, 1975

8 Galaal K, "Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): protocol for a randomised controlled feasibility study" 2018

9 Menitove JE, "Transfusion related acute lung injury (TRALI): a review" 104 : 270-275, 2007

10 Sarda P, "Topical usage of tranexamic acid: comparative analysis in patients with bilateral total knee replacement" 7 : 182-187, 2017

11 Davis M, "The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence?" 91 : 474-476, 2003

12 Mirhashemi R, "The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer" 181 : 1310-1315, 1999

13 Karczewski DM, "The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery" 78 : 1131-1135, 1994

14 Lane TA, "The effect of storage on the metastatic potential of tumor cells collected in autologous blood. An animal model" 29 : 418-420, 1989

15 Spahn DR, "The chiasm: transfusion practice versus patient blood management" 27 : 37-42, 2013

16 Kobayashi T, "Surgical intervention for vertebral metastases may benefit lung cancer patients no less than other patients: a retrospective study" 11 : 4-, 2017

17 Witham TF, "Surgery insight: current management of epidural spinal cord compression from metastatic spine disease" 2 : 87-94, 2006

18 Krajewski K, "Successful blood conservation during craniosynostotic correction with dual therapy using procrit and cell saver" 19 : 101-105, 2008

19 Yamaguchi K, "Significant detection of circulating cancer cells in the blood by reverse transcriptasepolymerase chain reaction during colorectal cancer resection" 232 : 58-65, 2000

20 Dale RF, "Separation of malignant cells during autotransfusion" 75 : 581-, 1988

21 Han S, "Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma" 264 : 339-343, 2016

22 Wells PS, "Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review of the literature" 9 : 377-388, 2002

23 Terraube V, "Role of von Willebrand factor in tumor metastasis" 120 (120): S64-S70, 2007

24 Kato S, "Risk of infectious complications associated with blood transfusion in elective spinal surgery-a propensity score matched analysis" 16 : 55-60, 2016

25 Choi D, "Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group" 19 : 215-222, 2010

26 Beck-Schimmer B, "Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion" 21 : 46-52, 2004

27 Islam N, "Post-traumatic immunosuppression is reversed by anti-coagulated salvaged blood transfusion: deductions from studying immune status after knee arthroplasty" 177 : 509-520, 2014

28 Bower MR, "Phase II comparison study of intraoperative autotransfusion for major oncologic procedures" 18 : 166-173, 2011

29 Zaw AS, "Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery?" 57 : 440-450, 2017

30 Gorin MA, "Oncologic outcomes following radical prostatectomy with intraoperative cell salvage" 30 : 379-383, 2012

31 Botteri E, "Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer" 122 : 211-217, 2010

32 Pennington Z, "Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence" 6 : 103-, 2018

33 Zaw AS, "Metastatic spine tumor surgery: does perioperative blood transfusion influence postoperative complications?" 57 : 2790-2798, 2017

34 Kumar N, "Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture" 27 (27): 327-334, 2017

35 Fidler IJ, "Macrophages and metastasis: a biological approach to cancer therapy" 45 : 4714-4726, 1985

36 Hirano T, "Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma" 35 : 1042-1046, 2005

37 Kim JM, "Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter" 26 : 84-89, 2013

38 Foltys D, "Liver transplantation for hepatocellular carcinoma: is there a risk of recurrence caused by intraoperative blood salvage autotransfusion?" 47 : 182-187, 2011

39 Kumar N, "Is salvaged autogenic blood transfusion safe in metastatic spine surgery: a preliminary report from a prospective clinical trial" National University Hospital 2018

40 Zaw AS, "Is autologous salvaged blood a viable option for patient blood management in oncologic surgery?" 31 : 56-61, 2017

41 Bridgens JP, "Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study" 89 : 270-275, 2007

42 Ubee S, "Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis" 93 : 157-161, 2011

43 Gray CL, "Intraoperative cell salvage in radical retropubic prostatectomy" 58 : 740-745, 2001

44 Raval JS, "Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality" 52 : 2590-2593, 2012

45 Kumar N, "Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for reinfusion of viable cancer cells" 25 : 4008-4015, 2016

46 Nieder AM, "Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate" 65 : 730-734, 2005

47 Nieder AM, "Intraoperative cell salvage during radical cystectomy does not affect long-term survival" 69 : 881-884, 2007

48 Dzik WH, "Intraoperative blood salvage: medical controversies" 4 : 208-235, 1990

49 Williamson KR, "Intraoperative blood salvage: a review" 31 : 662-675, 1991

50 Waters JH, "Intraoperative blood recovery" 59 : 11-17, 2013

51 Klimberg I, "Intraoperative autotransfusion in urologic oncology" 121 : 1326-1329, 1986

52 Hart OJ 3rd, "Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder" 168 : 302-306, 1989

53 Poli M, "Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker" 95 : 308-312, 2008

54 Connor JP, "Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix" 86 : 373-378, 1995

55 Esper SA, "Intra-operative cell salvage: a fresh look at the indications and contraindications" 9 : 139-147, 2011

56 Park KI, "Intra-operative autotransfusion in radical cystectomy" 79 : 717-721, 1997

57 Salaria ON, "Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients" 118 : 1179-1187, 2014

58 MacIvor D, "Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy" 49 : 1431-1434, 2009

59 Sawhney M, "Guidelines on management of pain in cancer and/or palliative care, Program in Evidence-Based Care Evidence Summary No.: 18-4" 2017

60 Kumar N, "Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery" 21 : 4330-4335, 2014

61 Martin RC, "Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy" 12 : 1017-1024, 2005

62 Jacobs WB, "Evaluation and treatment of spinal metastases: an overview" 11 : e10-, 2001

63 Davis RJ, "Erythrocyte viability in postoperative autotransfusion" 13 : 781-783, 1993

64 Colwell CW Jr, "Erythrocyte viability in blood salvaged during total joint arthroplasty with cement" 84-A : 23-25, 2002

65 Perseghin P, "Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients" 72 : 221-224, 1997

66 Ford BS, "Effect of perioperative blood transfusion on prostate cancer recurrence" 26 : 364-367, 2008

67 Gharehbaghian A, "Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency" 363 : 1025-1030, 2004

68 Liang J, "Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion? A prospective randomized study" 24 : 270-275, 2015

69 Araujo RL, "Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?" 8 : 161-168, 2016

70 Chambers AF, "Dissemination and growth of cancer cells in metastatic sites" 2 : 563-572, 2002

71 Cristofanilli M, "Circulating tumor cells, disease progression, and survival in metastatic breast cancer" 351 : 781-791, 2004

72 Moreno JG, "Circulating tumor cells predict survival in patients with metastatic prostate cancer" 65 : 713-718, 2005

73 de Bono JS, "Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer" 14 : 6302-6309, 2008

74 Danila DC, "Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer" 13 : 7053-7058, 2007

75 Allan AL, "Circulating tumor cell analysis: technical and statistical considerations for application to the clinic" 2010 : 426218-, 2010

76 Carless PA, "Cell salvage for minimising perioperative allogeneic blood transfusion" 2010

77 Ashworth A, "Cell salvage as part of a blood conservation strategy in anaesthesia" 105 : 401-416, 2010

78 Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012" 136 : E359-E386, 2015

79 Kumar N, "Can there be a place for intraoperative salvaged blood in spine tumor surgery?" 21 : 2436-2443, 2014

80 Muscari F, "Blood salvage autotransfusion during transplantationfor hepatocarcinoma: does it increase the risk of neoplastic recurrence?" 18 : 1236-1239, 2005

81 Waters JH, "Blood salvage and cancer surgery: a meta-analysis of available studies" 52 : 2167-2173, 2012

82 Chen Y, "Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis" 95-B : 683-688, 2013

83 Kumar N, "Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors" 23 : 2079-2086, 2016

84 Fujimoto J, "Autotransfusion in hepatectomy for hepatocellular carcinoma" 92 : 825-830, 1991

85 Klimberg IW, "Autotransfusion and blood conservation in urologic oncology" 5 : 286-292, 1989

86 Vanderlinde ES, "Autologous transfusion" 324 : 772-775, 2002

87 "Autologous blood transfusions. Council on scientific affairs" 256 : 2378-2380, 1986

88 Kumar N, "Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery?" 25 : 3997-4007, 2016

89 Stoffel JT, "Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy" 96 : 313-315, 2005

90 Chalfin HJ, "Allogeneic versus autologous blood ransfusion and survival after radical prostatectomy" 54 : 2168-2174, 2014

91 Janssen SJ, "Allogeneic blood transfusions and postoperative infections after lumbar spine surgery" 15 : 901-909, 2015